Korean J Helicobacter Up Gastrointest Res.
2023 Dec;23(4):237-239. 10.7704/kjhugr.2023.0062.
Does Types of 23S-Ribosomal RNA Point Mutations Affect Helicobacter pylori Eradication Rate in Clarithromycin-Based Triple Therapy?
- Affiliations
-
- 1Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
- KMID: 2548710
- DOI: http://doi.org/10.7704/kjhugr.2023.0062
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Eradication Therapy for Helicobacter pylori with Diagnostic Test for Clarithromycin Resistance
- Types of 23S Ribosomal RNA Point Mutations Affecting Helicobacter pylori Eradication Rates in Clarithromycin-Based Triple Therapy
- Types of 23S Ribosomal RNA Point Mutations and Therapeutic Outcomes for Helicobacter pylori
- Clarithromycin-Based Standard Triple Therapy Can Still Be Effective for Helicobacter pylori Eradication in Some Parts of the Korea
- The Effect of Concomittent Therarpy and Quadruple Therapy for Patients Who Had 23S Ribosomal Ribonucleic Acid Mutated Helicobacter pylori in Daegu and Kyoungpook Area
